Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Leveraging natural killer cells for cancer immunotherapy.
Grossenbacher SK, Aguilar EG, Murphy WJ. Grossenbacher SK, et al. Immunotherapy. 2017 May;9(6):487-497. doi: 10.2217/imt-2017-0013. Immunotherapy. 2017. PMID: 28472904 Free PMC article. Review.
Models to Study NK Cell Biology and Possible Clinical Application.
Zamora AE, Grossenbacher SK, Aguilar EG, Murphy WJ. Zamora AE, et al. Among authors: grossenbacher sk. Curr Protoc Immunol. 2015 Aug 3;110:14.37.1-14.37.14. doi: 10.1002/0471142735.im1437s110. Curr Protoc Immunol. 2015. PMID: 26237009 Free PMC article. Review.
NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype.
Ames E, Canter RJ, Grossenbacher SK, Mac S, Chen M, Smith RC, Hagino T, Perez-Cunningham J, Sckisel GD, Urayama S, Monjazeb AM, Fragoso RC, Sayers TJ, Murphy WJ. Ames E, et al. Among authors: grossenbacher sk. J Immunol. 2015 Oct 15;195(8):4010-9. doi: 10.4049/jimmunol.1500447. Epub 2015 Sep 11. J Immunol. 2015. PMID: 26363055 Free PMC article.
Targeting Cancer Stem Cells with Natural Killer Cell Immunotherapy.
Luna JI, Grossenbacher SK, Murphy WJ, Canter RJ. Luna JI, et al. Among authors: grossenbacher sk. Expert Opin Biol Ther. 2017 Mar;17(3):313-324. doi: 10.1080/14712598.2017.1271874. Epub 2016 Dec 23. Expert Opin Biol Ther. 2017. PMID: 27960589 Free PMC article. Review.
Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trial.
Canter RJ, Grossenbacher SK, Foltz JA, Sturgill IR, Park JS, Luna JI, Kent MS, Culp WTN, Chen M, Modiano JF, Monjazeb AM, Lee DA, Murphy WJ. Canter RJ, et al. Among authors: grossenbacher sk. J Immunother Cancer. 2017 Dec 19;5(1):98. doi: 10.1186/s40425-017-0305-7. J Immunother Cancer. 2017. PMID: 29254507 Free PMC article. Clinical Trial.
Treatment of chronic graft-versus-host disease with bortezomib.
Pai CC, Chen M, Mirsoian A, Grossenbacher SK, Tellez J, Ames E, Sun K, Jagdeo J, Blazar BR, Murphy WJ, Abedi M. Pai CC, et al. Among authors: grossenbacher sk. Blood. 2014 Sep 4;124(10):1677-88. doi: 10.1182/blood-2014-02-554279. Epub 2014 Jul 9. Blood. 2014. PMID: 25009225 Free PMC article. Clinical Trial.
Bystander activation and anti-tumor effects of CD8+ T cells following Interleukin-2 based immunotherapy is independent of CD4+ T cell help.
Monjazeb AM, Tietze JK, Grossenbacher SK, Hsiao HH, Zamora AE, Mirsoian A, Koehn B, Blazar BR, Weiss JM, Wiltrout RH, Sckisel GD, Murphy WJ. Monjazeb AM, et al. Among authors: grossenbacher sk. PLoS One. 2014 Aug 13;9(8):e102709. doi: 10.1371/journal.pone.0102709. eCollection 2014. PLoS One. 2014. PMID: 25119341 Free PMC article.
17 results